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Abstract
Clostridium difficile is the principal cause of antibiotic-associated diarrhea. Major metabolic
requirements for colonization and expansion of C. difficile after microbiota disturbance have
not been fully determined. In this study, we show that glutamate utilization is important for
C. difficile to establish itself in the animal gut. When the gluD gene, which codes for gluta-
mate dehydrogenase (GDH), was disrupted, the mutant C. difficile was unable to colonize
and cause disease in a hamster model. Further, from the complementation experiment it
appears that extracellular GDH may be playing a role in promoting C. difficile colonization
and disease progression. Quantification of free amino acids in the hamster gut during C. dif-
ficile infection showed that glutamate is among preferred amino acids utilized by C. difficile
during its expansion. This study provides evidence of the importance of glutamate metabo-
lism for C. difficile pathogenesis.
Introduction
Clostridium difficile, a major nosocomial pathogen, is the principal causative agent of antibi-
otic-associated diarrhea and pseudomembranous colitis [1,2,3]. Antibiotic use is the primary
risk factor for development of C. difficile infection because it disrupts the normal protective gut
flora and enables C. difficile to colonize the colon [4]. C. difficile spores are typically ingested
and germinate inside the host. Bile salts, such as taurocholate, are known to induce germina-
tion of C. difficile spores in the gut [5]. Once germinated, the outgrowing vegetative cells colo-
nize the gut where they eventually produce toxins A and B, virulence factors that damage the
intestinal tissues resulting in C. difficile infection [6,7]. In vitro studies of C. difficile have dem-
onstrated that transcription of toxin genes is tightly linked with various bacterial metabolic reg-
ulatory networks, and is activated in response to various nutritional signals
[8,9,10,11,12,13,14,15]. Here, we sought to determine the metabolic requirements for multipli-
cation and colonization of C. difficile in the host gut.
Studies on metabolism and nutritional requirements of C. difficile have indicated that it can
ferment free amino acids, and the preferred substrates are low molecular weight peptides [16,17].
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Since glutamate is central in amino acid metabolism, and biosynthesis of many other amino acids
depend on glutamate, we hypothesized that the ability of C. difficile to colonize the gut might be
dependent on the glutamate utilization pathway. Glutamate dehydrogenases (GDH) are a broadly
distributed group of enzymes [18,19] that catalyze the oxidative deamination of glutamate to α-
ketoglutarate and ammonia (Glutamate + NAD+ + H2O αKG + NADH +H
+ + NH4
+). Some
GDH enzymes also catalyze a reverse reaction that generates glutamate by condensation of
ammonia and α-ketoglutarate. The physiological role of GDH as either an anabolic or catabolic
enzyme is determined by its cofactor specificity (NAD or NADH, NADP or NADPH). In C. diffi-
cile, the GDH enzyme is NAD-specific, and mediates the oxidative deamination of glutamate to
produce α-ketoglutarate and ammonia [20]. Each of these products plays important roles in
amino acid metabolism in all organisms.
GDH specific Enzyme Immuno Assays (EIA) for the detection of C. difficile are commercially
available. Detection of C. difficile is currently performed as a two-step process. An ELISA for C.
difficileGDH is performed first, and GDH-positive specimens are tested further for toxin pro-
duction by ELISA [21,22]. The effectiveness of GDH as a diagnostic marker is well-documented
[21,22]. However, the importance of GDH for C. difficile pathogenesis is not known [21,22]. We
previously created a GDH (gluD) mutant in C. difficile JIR8094 strain, and found that the mutant
was more sensitive to hydrogen peroxide than the parent strain [23]. We have also shown that C.
difficile-derived GDH can be detected extracellularly [23]. Here, we investigated the importance
of GDH in colonization and pathogenesis of C. difficile. In a hamster model, we found that C. dif-
ficileGDH (gluD) mutant failed to colonize the animals or to cause disease. Furthermore, our
results indicated that extracellular GDH from C. difficilemight play a role in supporting bacterial
colonization in the gut. This is the first time its been demonstrated that a specific amino acid met-
abolic pathway is essential for C. difficile pathogenesis.
Materials and Methods
Bacterial strains and growth conditions
C. difficile strains, JIR8094 [24] and the JIR8094:: gluDmutant (Table 1), Clostridium sordellii
strain ATCC 9084 [25] and Clostridium perfringens strain SM125 [26] were grown anaerobi-
cally (10% H2, 10% CO2 and 80% N2) in TY broth or TY agar as described previously
[23,25,27]. Bacillus subtilis strain 168 was grown aerobically in LB medium [28]. E. coli strain
S17-1 [29] used for conjugation was cultured aerobically in LB medium supplemented as
needed for selection with chloramphenicol (30 μg ml-1) or ampicillin (100 μg ml-1). All routine
cloning and plasmid constructions (Table 1) were carried out using standard procedures. Oli-
gonucleotides used in this study are listed in S1 Table.
Complementation of C. difficile gluDmutant with GDH coding regions of
different bacterial sources
The gluDmutant complemented was with C. difficile gluD as described in our earlier study
[23]. Briefly, the gluD ORF with its upstream regions (840 bps) along with its ribosomal bind-
ing site was PCR amplified from JIR8094 chromosomal DNA, using primers gluDP(F) and
gluDP(R) (S1 Table), which carried restriction sitesHindIII and XbaI respectively. The resulted
PCR product was digested withHindIII and XbaI and was cloned into pMTL84151 digested
with the same to yield pRG51. The gluDORF was PCR amplified from JIR8094 chromosomal
DNA using primers ORG72 (with KpnI) and ORG79 (with SacI) and the PCR product was
digested with KpnI and SacI and cloned into the pRGL51 to construct plasmid pRGL58, where
the gluD was expressed from its native promoter. Similarly, the gluD homologues from C.
Clostridium difficileGlutamate Dehydrogenase
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perfringens, C. sordellii and B. subtilis were PCR amplified from their chromosomal DNA using
primers with KpnI and SacI (S1 Table) and cloned into pRG51 to construct plasmids
pRGL316, pRGL315 and pRGL75 respectively, where they were expressed from the C. difficile
gluD promoter. To express C. difficile GDH without the last 20 C terminal amino acids (gluD-
20C), primers ORG72 and ORG303 were used to construct pRGL164. To express C. difficile
GDH without the first 20 N terminal amino acids (gluD-20N), primers ORG361 and ORG79
were used to construct pRGL79. The GDH expressing plasmids and the vector pMTL84151
were introduced into JIR8094 and gluDmutant C. difficile strains by conjugation [23,25].
Transconjugants carrying different gluD constructs or the vector pMTL84151 were grown
overnight in TY medium supplemented with thiamphenicol. 10 ml of fresh cultures were inoc-
ulated with 100μl of overnight cultures and were grown for 6 hours in TY medium with thiam-
phenicol. Bacterial cells and the culture supernatants were harvested for the detection of GDH.
Accession numbers for C. perfringens gluD, C. sordellii gluD and B. subtilis rocG genes are
ABG85534.1, EPZ61548.1 and NP_391659.2, respectively.
Table 1. Bacterial strains/ plasmids used in this study.
Strain/ Plasmids Description Sources
JIR8094 Erythromycin sensitive derivate of C. difﬁcile 630 strain [24]
JIR8094-gluDmutant C. difﬁcile JIR8094 with intron insertion within gluD gene [23]
DH5α E.coli strain—endA1 recA1 deoR hsdR17 (rK
- mK
+) NEB labs
S17-1 E.coli strain–favors conjugation [29]
SM125 Clostridium perfringens [26]
BS168 Bacillus subtilis [28]
ATCC9084 Clostridium sordellii [25]
pMTL007E5:Cdi-gluD-
324a
pMTL007C-E5 carrying gluD speciﬁc intron This
study
pMTL84151 Shuttle vector for C. difﬁcile [63]
pRGL51 gluD promoter (840 bps of gluD upstream) cloned in pMTL84151 [23].
pRGL315 Clostridium sordellii gluD in pRG51 This
study
pRGL316 Clostridium perfringens gluD in pRG51 This
study
pRGL75 Bacillus subtilis rocG in pRG51 This
study
pRGL58 C. difﬁcile gluD in pRG51 [23]
pRGL77 Modiﬁed C. difﬁcile gluD in pRG51 to express GDH without 20 N
terminal amino acids (GDH-20N)
This
study
pRGL164 Modiﬁed C. difﬁcile gluD in pRG51 to express GDH without 20 C
terminal amino acids (GDH-20C)
This
study
gluDmutant
+pMTL84151
gluDmutant with vector pMTL84151 This
study
gluDmutant + pRGL51 gluDmutant expressing C. difﬁcileGDH [23]
gluDmutant
+ pRGL315
gluDmutant expressing C. sordelliiGDH This
study
gluDmutant
+ pRGL316
gluDmutant expressing C. perfringensGDH This
study
gluDmutant +pRGL77 gluDmutant expressing GDH -20N This
study
gluDmutant
+ pRGL164
gluDmutant expressing GDH -20C This
study
JIR8094+ pMTL84151 Wild type C. difﬁcile with vector pMTL84151 This
study
doi:10.1371/journal.pone.0160107.t001
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GDH Zymogram and ELISA
Culture supernatants and the cytosolic proteins collected from various GDH expressing bacte-
rial cultures were subjected to GDH in gel activity analysis following the protocol described by
Okwumabua et al. [30]. The culture supernatants were concentrated 10 folds using the Amicon
8000 series stirred cell fitted with an ultra-filtration membrane with molecular weight cut off
range of 10 kDa. The concentrated supernatant and cytosolic extracts were subjected to non-
denaturing polyacrylamide gel electrophoresis (PAGE). The samples were resuspended in sam-
ple buffer devoid of any denaturing agents and were separated in non-SDS polyacrylamide
gels. Electrophoresis was performed in tris-glycine buffer without SDS at 50 Volts. Proteins
with NAD specific GDH activity were visualized by immersing the gels in 20ml of 20 mM Tris
HCL (pH8.0) reaction buffer with, Nitro Blue Tetrazolium, 0.3 mg/ml; phenazine methosul-
fate, 0.05 mg/ml. To detect NAD or NADH specific GDH activity, either L-glutamate with
0.5 mM NAD or 50 mM alpha ketoglutarate with 1 mMNADH were added to the reaction
buffer respectively. GDH activity could be detected as the purple colored bands in the gels. The
presence of C. difficile GDH in the cecal contents was detected with a commercially available
ELISA kit (CDiff Check ™- 60, TechLab Inc., Blacksburg, Va.) in accordance with the manufac-
turer's instructions.
Hamster model
Male Syrian golden hamsters (100–120 g) were used for C. difficile infection. They were housed
individually in sterile cages with ad libitum access to food and water for the duration of the
study. In some experiments when hamsters were challenged with C. difficile carrying a plasmid
constructs, thiamphenicol was given to the hamsters through their drinking water at a concen-
tration of 30 mg per liter to select for retention of the plasmid. Fecal pellets were collected from
all hamsters, homogenized in 1 ml saline, and examined for C. difficile by plating on CCFA-TA
(Cycloserine Cefoxitin Fructose Agar- 0.1% Taurocholate) to ensure that the animals did not
harbor indigenous C. difficile. After this initial screening for C. difficile, hamsters were gavaged
with 30 mg/kg clindamycin [31,32]. Vegetative C. difficile cells were used to infect the hamsters.
To standardize the preparation of the bacterial inoculums, 100 μl of an overnight culture was
inoculated into 10 ml TY broth medium and grown for 12 hours. A 1 ml sample of the expo-
nentially growing culture was washed once with sterile PBS. The absorbance was then adjusted
to 1.0 at OD600 nm. Serial dilutions prepared in sterile PBS were used to enumerate bacterial
cell counts. Inoculums were prepared as a 200 μL sample standardized to contain approxi-
mately 2000 bacterial cells. Inocula were prepared immediately prior to challenge. The inocu-
lums needed to infect each animal were transported in an independent 1.5 ml Eppendorf tube
to the vivarium using the Remel AnaeroPackTM system (one box for each strain) to maintain
viability. Immediately before and after infecting the animal a 10 μL sample of the inoculum
was plated onto TY with cefoxitine agar to confirm the bacterial count and viability. Seven ani-
mals per strain were used for the infection. In each experiment, 4 animals were used as unin-
fected controls, and received only antibiotics and sterile PBS. Infection was initiated 4 days
after clindamycin administration by gavage with 2,000 vegetative cells. Animals were moni-
tored for signs of disease (lethargy, poor fur coat, sunken eyes, hunched posture, and wet tail)
every four hours (six times per day) throughout the study period. Hamsters were scored from
1 to 5 for the signs mentioned above (1-normal and 5-severe). Fresh fecal pellets were collected
daily from every animal to monitor C. difficile colonization (see the supporting information)
until they began developing diarrheal symptoms. Hamsters showing signs of severe disease
(a cumulative score of 12 or above) were euthanized by CO2 asphyxiation. Surviving hamsters
were euthanized 15 days after C. difficile infection. Thoracotomy was performed as a secondary
Clostridium difficileGlutamate Dehydrogenase
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mean of death and the cecal samples (contents and tissues) were collected for further analysis.
H&E (Hematoxylin and Eosin) staining of cecal tissues were performed. The data were graphed
as Kaplan-Meier survival analyses, and compared for statistical significance using the log-rank
test using GraphPad Prism 6 software (GraphPad Software, San Diego, CA). All animal studies
were conducted with prior approval from the Kansas State University’s Institutional Animal
Care and Use Committee.
Histology and inflammation scoring
The ceca were removed and opened longitudinally, and washed in PBS. Full-thickness sections
were fixed in formalin, paraffin embedded, and stained with hematoxylin and eosin. Severity of
enteritis and colitis was graded using the three parameters as published previously: i) epithelial
tissue damage; ii) mucosal edema; iii) neutrophil infiltration [33,34]. Trained pathologists at
KSU diagnostic lab scored the blinded samples from 1 to 3 to each parameter mentioned
above. Total histology score (from 0 to 9) was determined by the sum of all these three parame-
ter scores. Results were expressed as mean ± standard error of the mean (SEM) and were ana-
lyzed by using the Prism professional statistics software program (GraphPad, San Diego, CA).
Unpaired Student t tests were used for intergroup comparisons. P values of statistically signifi-
cant differences are shown in each figure.
Bacterial load measurement and detection in cecal contents
At sacrifice, cecal contents harvested and were processed as follows. The cecal materials from
the uninfected and the hamsters that survived the C. difficile challenge were thick in their con-
sistence. These materials were resuspended in sterile PBS and were centrifuged (20,000 × g for
5 min at 4°C) to collect the supernatants. The cecal materials from the hamsters that came
down with C. difficile disease were watery and were clarified by centrifugation. The superna-
tants collected after centrifugation were stored at -80°C and were later used for GDH ELISA.
One gram of cecal slurry collected after the centrifugation contents were resuspended in sterile
1 ml PBS, serially diluted and were plated on CCFA-TA (Cycloserine Cefoxitin Fructose Agar
with 0.1% Taurocholate) to quantify C. difficile, which appeared as yellow colonies. Results
were presented as cfu per gram.
Amino acid analysis of cecal contents
Cecal contents from hamsters were weighed at necropsy and flash frozen in liquid nitrogen. Sam-
ples were sent to the University of Michigan, Metabolomics Resource Core for amino acid analy-
sis. Amino acids were analyzed using the EZ-faast kit from Phenomenex–Torrance, CA
following the instructions provided by the manufacturer. Samples were extracted, semi-purified,
derivatized by a proprietary method, and analyzed by EI-GCMS using internal standards for nor-
malization. Analytes were reported as nM/mg of cecal content. Fold changes between clindamy-
cin treated vs. non-antibiotic treated controls, and clindamycin treated vs. C. difficile infected
colon samples, were evaluated byWelch's t-test; p<0.05 was considered to be significant.
Results
GDH is important for C. difficile colonization and infection in hamsters
To understand the importance of GDH in C. difficile pathogenesis, we used a hamster model in
which C. difficile infection is known to cause severe disease symptoms [31]. Syrian male ham-
sters were gavaged with 2,000 vegetative cells of C. difficile strain JIR8094 or its gluDmutant
and monitored for signs of C. difficile infection. Fecal pellets were collected daily until animals
Clostridium difficileGlutamate Dehydrogenase
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developed diarrheal symptoms; total DNA was extracted and used for qPCR analysis of C. diffi-
cile 16S rRNA (S2A and S2B Table). Results showed that JIR8094 colonized the gut within two
days post-inoculation, but the gluDmutant either was unable to initiate colonization in ham-
sters or was rapidly cleared by the host (S2 Table). Animals infected with parental strain
JIR8094 succumbed to disease, whereas, the gluDmutant was avirulent (Fig 1). Cecal contents
from diseased hamsters were collected at sacrifice. Nearly fifteen days post C. difficile infection,
all surviving gluDmutant infected hamsters and uninfected control hamsters were sacrificed,
and their cecal contents were harvested. The bacterial load in the cecal samples was measured,
and cecal tissues were stained with H&E for microscopic evaluation of inflammation (Fig 2A).
GDH in the cecal contents was detected using the commercially available ELISA kit specific for
C. difficile GDH. As suspected, GDH could be readily detected in the cecal contents of the
JIR8094 infected hamsters but not in cecal contents of the gluDmutant (S1 Fig). Little or no
inflammation was observed in gluDmutant-infected animals; whereas, extensive inflammation
accompanied by crypt damage and the influx of inflammatory cells in the lamina propria and
sub-mucosa was observed in hamsters infected with the parental strain (Fig 2A). Mean histol-
ogy scores recorded for parent strain (JIR8094)-treated animals were significantly greater than
for gluDmutant-treated animals ( p<0.005). No or very low inflammation was recorded in
gluDmutant infected animals (Fig 2B). The cecal contents of JIR8094-infected hamsters con-
tained nearly 108 colony-forming units per gram; however, very few or no C. difficile cells were
detected in the cecal contents of gluDmutant-infected animals, suggesting that GDH is needed
for C. difficile colonization and subsequent disease progression in the host gut (Fig 2C).
C. difficile is unable to secrete C. difficileGDH homologues from B.
subtilis, C. sordellii, and C. perfringens
In an earlier study, we showed that C. difficile GDH is secreted from the bacteria during its
growth in TY medium [23]. Our finding of GDH in the cecal contents of the JIR8094-infected
hamsters suggested that the enzyme might also be secreted during C. difficile infection in the
host. To understand the importance of secreted GDH on C. difficile pathogenesis, we
Fig 1. GDH is required forC. difficile virulence. Kaplan-Meier survival curve of clindamycin-treated Syrian
hamsters inoculated with 2,000 vegetative cells of C. difficile JIR8094 (Parent) or C. difficile JIR8094::gluD
(mutant). Animals (n = 7 per group) were monitored every four hours for the symptoms of wet tail, poor fur
coat, lethargy, or hunched posture. Moribund animals were euthanized. Log rank statistical analysis was
performed; p <0.0001.
doi:10.1371/journal.pone.0160107.g001
Clostridium difficileGlutamate Dehydrogenase
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complemented the C. difficile gluDmutant with various gluD constructs in an attempt to create
a C. difficile strain with non-secreted GDH.
The first constructs used for complementation were different bacterial gluD homologues.
NAD-specific GDH encoding genes from B. subtilis, C. sordellii, and C. perfringens were ampli-
fied and cloned under the control of the C. difficile gluD promoter and its ribosome binding
site. The resulting constructs were introduced into the C. difficile gluDmutant, and were tested
for the expression and secretion of these non-native GDH enzymes. The B. subtilis, C. sordellii,
and C. perfringens GDH enzymes were detected in the cytosolic fractions of the respective
transfected C. difficile cultures. However, none of these GDH enzymes was detected in the cul-
ture supernatants (Fig 3A and 3B). This result suggests that C. difficile GDH is exported out
through a specific secretion mechanism in C. difficile. However, we also recognize that the
absence of C. sordellii, C. perfringens and B. subtilis GDH enzymes in the extracellular medium
Fig 2. C. difficile JIR8094::gluDmutant does not colonize or induce inflammation in hamsters. A. Representative colonic histologic images
(hematoxylin and eosin (H&E) staining). Cecal tissues from parental strain-infected hamsters were harvested at the time of sacrifice. Cecal tissues from
surviving gluDmutant-infected (and uninfected) hamsters were harvested 15 days post-infection. B. Histology scores were evaluated as described in the
Materials and Methods.C. C. difficile colonization levels for each of the two groups in CFU per gram of cecal content at the time of necropsy. In three of
seven gluDmutant-infected animals,C. difficile was not detected and are not represented in the figure (n = 7 per group). Error bars represent SD.
doi:10.1371/journal.pone.0160107.g002
Clostridium difficileGlutamate Dehydrogenase
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when expressed in C. difficilemay simply due to additional variations associated with their pro-
duction in this heterologous host. Further characterizations of these strains are currently under
progress in our lab.
In bacteria, many secreted proteins require signal peptides to be transported across the cyto-
plasmic membrane. To assess signal specific secretion of GDH in C. difficile, we created GDH
constructs lacking the 20 amino acids from either N terminal or C terminal part of the enzyme
and tested their secretion from C. difficile cells. Removal of 20 amino acid residues from the N-
terminus C. difficile GDH (GDH-20N) abolished its enzymatic activity (Fig 3C and 3D); how-
ever, secretion of GDH was not affected (Fig 3E). Removal of 20 amino acids from the C-termi-
nus of the protein (GDH-20C) did not affect either the enzymatic activity (Fig 3F and 3G) or
the secretion of GDH enzyme (Fig 3H).
Extracellular GDH appears to favor rapid C. difficile disease progression
in hamsters
Next, hamsters were inoculated with C. difficile gluDmutant strain complemented with differ-
ent gluD constructs. Initial in vitro growth experiments showed that all C. difficile strains used
in this experiment grew at same rate in TY medium (S2 Fig). The strains tested included the
gluDmutant complemented with nonsecretable-heterologous C. sordellii GDH, and secretable
native C. difficile GDH. The parental strain and gluDmutant carrying vector alone were used
as controls. Hamsters were monitored for disease symptoms every four hours, and moribund
animals were euthanized. DNA prepared from fecal pellets was subjected to qPCR to monitor
C. difficile colonization. Consistent with our initial experiment, the gluDmutant with vector
alone failed to colonize the animals or cause disease (Fig 4). The parental strain with vector and
Fig 3. Complementation of gluDmutant with various gluD constructs. The gluD homologues from closely related bacterial species were expressed in
the C. difficile gluDmutant strain, and their secretion from C. difficile was analyzed. Cytosolic (cyt) and concentrated supernatants (sup) from the bacterial
cultures expressing various gluD constructs were separated by SDS-PAGE, and were analyzed by Coomassie staining (A) and by zymogram (B). C. difficile
gluD constructs with deletions of their N-terminus (panelsC, D, and E) or of C-terminus (panels F,G andH) were expressed inC. difficile gluDmutant, and
their secretion from C. difficilewas analyzed by zymogram (D&G) and ELISA (E&H).
doi:10.1371/journal.pone.0160107.g003
Clostridium difficileGlutamate Dehydrogenase
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the gluDmutant complemented with wild-type GDH colonized and caused disease more rap-
idly than did the gluDmutant complemented with the nonsecretable C. sordellii GDH. The
inflammation scores of these groups were also significantly lower than groups that received the
parental strain or the gluDmutant complemented with secretable C. difficile GDH (Fig 5A and
5B). Nonetheless, hamsters that were infected with C. difficile strains that produce heterolo-
gous- nonsecretable form of GDH eventually showed signs of infection. C. difficile was detected
in cecal contents and the strains that produce C. sordellii GDH were able to colonize the gut
successfully (Fig 5C). However, fewer C. difficile cells per gram of cecal content were detected
in animals infected with C. difficile expressing nonsecretable GDH than those expressing secre-
table forms. This experiment confirmed that GDH was essential for colonization by C. difficile
in the host gut. From these results it also appear that presence of extracellular GDHmay favor
rapid bacterial colonization.
Co-infection with the parental strain supports colonization by gluD
mutant in vivo
Hamsters were infected with*1000 CFU each of parent and gluDmutant cells following clin-
damycin treatment. The hamsters developed diarrhea at approximately two days post-inocula-
tion, and became moribund at approximately four days post-inoculation (S3 Fig). Cecal
contents were harvested, and parental and gluDmutant bacterial loads were quantified by plat-
ing on CCFA-TA and CCFA-TA with erythromycin. We detected approximately 103 gluD
mutant bacteria and 105 parental bacteria per gram of cecal content (Fig 6). These results sug-
gested that the gluDmutant was able to proliferate to certain extent in the presence of the
parental strain. It is likely that extracellular GDH produced by the parental strain or GDH
released from the parental strain on lysis supported the growth of gluDmutant in the host gut.
Glutamate in the colon is rapidly utilized by proliferating C. difficile
It is well established that clindamycin treatment predisposes hamsters to C. difficile infection
[31]. Antibiotic treatments are known to bring dramatic change in the microbial gut
Fig 4. Extracellular GDH enables rapid progression ofC. difficile infection in hamsters.C. difficile gluD
mutant complemented with secretable C. difficileGDH or with nonsecretable C. sordelliiGDH were used to
infect the clindamycin-treated hamsters. Survival rate was plotted using Kaplan-Meier survival curve.
Comparisons of C. difficileGDH-WT vs.C. sordelliiGDH survival curves were made using long rank test;
p = 0.035.
doi:10.1371/journal.pone.0160107.g004
Clostridium difficileGlutamate Dehydrogenase
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community, which alters the metabolic environment within the gut [35,36]. Here, we measured
changes in the amino acid pool within the hamster colon following antibiotic treatment and C.
difficile infection.
In this experiment, the first group of hamsters did not receive any treatments and were used
as controls (S4 Fig). The second group received clindamycin alone at a concentration of 30 mg/
kg weight and was sacrificed six days after antibiotic treatment. The third and fourth groups
received clindamycin, and four days later were inoculated with 2000 cells of the parental strain
(JIR8094) or gluDmutant, respectively. Since we observed colonization of JIR8094 within two
days after infection (S2 Table) we chose to sacrifice the C. difficile infected hamsters two days
after gavaging the animals with C. difficile. Cecal contents were harvested from the sacrificed
hamsters, their bacterial load was measured in cecal contents by plating on CCFA-TA; and free
amino acid content was quantified as described in Methods (Table 2). Nearly 105 CFU of C. dif-
ficile JIR8094 and 0 to100 CFU of gluDmutant cells were detected per gram of cecal contents.
Fig 5. C. difficile gluDmutant complemented with secretable forms of GDH colonized better and inducedmore inflammation than the mutant
expressing nonsecretable GDH. A. Representative image of H&E stained colonic specimens. B. Histology scores evaluated as described in the Materials
and Methods section.C. C. difficile colonization levels for each of the groups (CFU per gram of cecal content at the time of necropsy). Unpaired t test was
performed for statistical analysis (n = 7 per group). Error bars represent SD.
doi:10.1371/journal.pone.0160107.g005
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Alanine, asparagine, glycine, lysine, isoleucine, methionine, valine, proline, serine, threonine,
and ornithine concentrations were increased more than four-fold in clindamycin-treated ani-
mals compared to controls. Clindamycin treatment also resulted in two- and three-fold
increases in glutamate and glutamine concentrations, respectively. However, glutamate and
glutamine concentrations dramatically decreased (30- to 40-fold) after C. difficile growth in the
colon, suggesting that these amino acids were preferentially utilized by C. difficile in the gut.
The data also suggested that ornithine, proline, isoleucine, lysine, serine, and threonine were
also used by C. difficile for growth in hamster colon. The amino acid concentrations in colon
contents of hamsters infected with the gluDmutant were similar to those in hamsters that
received only antibiotics (Table 2). These results reconfirmed our observation that gluD
mutants do not have the ability to multiply in the hamster gut. These data provide new insight
into C. difficile in vivometabolism, and suggest that the ability to metabolize amino acids may
be important for in vivo colonization and subsequent disease progression.
Discussion
Glutamate is a key metabolite that serves as a link between carbon and nitrogen metabolism
[37]; nearly 88% of cellular nitrogen comes from glutamate [38]. Glutamate metabolism has
been shown to be important for the virulence of bacterial pathogens Staphylococcus aureus
[39], Neisseria meningitides [40], and Helicobacter pylori [41]. In this study, we found that glu-
tamate utilization is essential for C. difficile colonization in vivo and for subsequent disease
Fig 6. Colonization of hamster gut byC. difficile gluDmutant in the presence of parentalC. difficile
strain.Hamsters were gavaged with a bacterial mixture containing 1000 parent and 1000 gluDmutant cells.
Bacterial load of each strain at the time of necropsy was measured and presented as CFU per gram of cecal
content. Unpaired t test was performed for statistical analysis (n = 7 per group). Error bars represent SD.
doi:10.1371/journal.pone.0160107.g006
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progression. The only previously known forms of C. difficile avirulence in the hamster model
were toxin A and B double mutant strains [42,43]. Thus, our finding that C. difficile depends
on free amino acids (especially glutamate) for its colonization and virulence in the host gut is
an important observation. The strain JIR8094 is regularly used to create mutants in various
genes, including the ones involved in metabolic functions and are used in hamsters for C. diffi-
cile pathogenesis studies [44,45,46,47]. This strain however is non-motile and was shown to
produce moderate amount of toxins than the closely related 630Δerm strain [48]. Hence it is
possible that deletion of GDH is this background might have attenuated its virulence to greater
extent. In a previous study, we showed that a C. difficile gluDmutant grew more slowly in TY
Table 2. Amino acid analyses of hamster cecal contents.
Amino Acids Clindamycin/ No
Clindamycin(Positive fold
change)
p value Clindamycin/ Clindamycin +C.
difﬁcile (Parent strain). (Positive
fold change)
p value Clindamycin/ Clindamycin + C.
difﬁcile (gluDmutant)(Positive fold
change)
p value
Alanine 4.906 1.02E-
04
0.4325 1.78E-
03
3.512 2.67E-
04
Asparagine 6.45 2.75E-
03
1.21 1.03E-
03
4.51 1.51E-
04
Aspartate 0.249 1.04E-
03
0.530 2.05E-
04
0.491 1.74E-
04
Glutamine 3.39 5.12E-
05
30.28 1.89E-
02
3.12 1.45E-
04
Glutamate 2.58 4.13E-
04
46.08 3.30E-
04
2.09 2.35E-
03
Glycine 11.21 1.12E-
03
2.68 6.72E-
04
9.09 3.62E-
04
Histidine 0.36 1.58E-
04
0.81 1.37E-
03
0.27 2.65E-
03
Isoleucine 6.15 1.46E-
04
17.90 1.93E-
02
5.89 2.36E-
04
Leucine 2.88 3.64E-
05
2.75 2.98E-
03
1.91 2.25E-
04
Lysine 9.92 1.33E-
04
7.10 1.96E-
03
8.32 2.57E-
03
Methionine 6.81 2.88E-
03
2.41 3.97E-
03
6.12 1.52E-
04
Phenylalanine 0.57 2.06E-
04
0.68 1.85E-
03
0.73 1.96E-
03
Proline 9.11 1.10E-
03
9.52 2.45E-
04
8.01 1.34E-
04
Serine 4.12 2.92E-
04
10.60 8.27E-
04
3.98 1.85E-
03
Threonine 9.85 4.03E-
05
11.71 6.56E-
04
8.76 2.78E-
04
Tryptophan 1.65 1.15E-
04
3.11 1.98E-
04
1.43 1.63E-
03
Tyrosine 0.58 1.12E-
03
0.29 2.89E-
04
0.47 1.59E-
03
Valine 12.67 4.56E-
03
3.30 1.49E-
03
10.21 1.76E-
04
α-Amino
isobutyric acid
1.67 2.09E-
03
0.562 2.16E-
04
1.39 1.70E-
04
Ornithine 41.13 2.10E-
04
52.05 1.45E-
04
38.29 3.42E-
03
doi:10.1371/journal.pone.0160107.t002
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medium than its parent strain during lag phase, but reached a similar growth rate as they
approached the logarithmic phase (S2 Fig) suggesting that under in vitro growth conditions,
the mutant C. difficilemight be using alternate pathways to compensate for the absence of
GDH. However, under in vivo conditions, the substrates for these alternative pathways may be
absent or the gene products of these pathways may not be expressed, resulting in complete ces-
sation of bacterial growth.
Susceptibility to C. difficile infection following antibiotic treatment in mice has been associ-
ated with an increase in the primary bile acid TCA, a germinant of C. difficile spores, as well as
by increases in amino acids, simple sugars, and sugar alcohols—growth substrates for C. diffi-
cile vegetative cells [49]. In another report, investigating the structure and function of the
microbiota following fecal microbiota transplantation in patients with recurrent C. difficile
infection, it was found that amino acid transport systems were downregulated following fecal
microbiota transplantation [50]. In our study, we measured the free amino acid contents of
cecal materials collected from C. difficile-infected hamsters, and found that C. difficile preferen-
tially utilizes certain amino acids including glutamate and glutamine. These findings support
the idea that amino acid metabolism is a key feature of C. difficile in vivo colonization. Interest-
ingly, a recent study reported that glutamate was least utilized by C. difficile when it was grown
in vitro in a casamino acids-containing medium [51]. The difference in amino acid utilization
by in vitro grown and in vivo grown cells is consistent with greater complexity of in vivometa-
bolic requirements for C. difficile growth, suggesting that it may be difficult to generate an in
vitro growth condition that closely mimics the in vivo growth requirements.
Typically, bacterial GDH enzymes are cytoplasmic or intracellular membrane-associated
proteins. In C. difficile, GDH was detected both in the cytoplasm and in extracellular culture
supernatants. We showed that C. difficile specifically secreted its own GDH but not GDH
enzymes introduced from closely related bacterial species. Using a hamster model, we have
provided additional evidence that secreted GDH is important for rapid colonization of C. diffi-
cile in vivo. Glutamate is the precursor of glutathione, a potent antioxidant in intestinal epithe-
lial cells [52]. By scavenging external glutamate in the intestine, C. difficilemay reduce
glutathione production by host cells or other microbes, which could help C. difficile induce
increased cellular damage in the intestine thereby facilitating more nutrient release from the
host. Glutamate receptors have also been identified in lymphocytes, and were found to influ-
ence their ability to modulate immune responses [53]. By scavenging glutamate, an important
signaling molecule, C. difficilemay influence a variety of host functions, including the immune
response.
In this study, we showed that extracellular GDH improves C. difficile colonization and dis-
ease progression. C. difficile GDH requires NAD as a co-substrate to metabolize extracellular
glutamate in the gut. NAD is present in all living cells, and certain types of cells are known to
secrete NAD+ and/or respond to NAD+ in the extracellular milieu [54,55,56]. NAD from intes-
tinal epithelial cells may be released into the gut lumen when during apoptosis associated with
renewal of intestinal epithelia. NAD is an unstable molecule, and it is often difficult to measure
its availability in biological samples. We were unsuccessful in our efforts to measure NAD in
cecal content of hamsters. However, in a recent report, it was shown that murine colon could
release NAD upon nerve stimulation associated with propulsion of gastrointestinal contents
[57]. Thus, it is reasonable to assume that sufficient NAD is available to meet the requirements
of C. difficile for extracellular GDH function in the colon. Similar to glutamate, NAD+ is also
known to acts as a signaling molecule in various cellular functions. In the intestine, extracellu-
lar NAD preserves intestinal epithelial barrier function [58]. Thus, by utilizing extracellular
NAD, C. difficile extracellular GDHmay enhance toxin-mediated damage to the intestinal bar-
rier in the host.
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Since we found that GDH is essential for C. difficile virulence, it will be interesting to test
whether extracellular GDH has a second function. There are many remaining questions: Does
GDH act as a glutamate sensor? How does C. difficile utilize GDH to harvest extracellular glu-
tamate? If extracellular GDH breaks down glutamate to alpha-keto glutarate and ammonia,
how are these energy producing molecules transported into C. difficile? Does extracellular
GDH associate with membrane bound transporters of alpha-keto glutarate and ammonia? In
B. subtilis the GlnK enzyme, which is needed for post translational modification of glutamine
synthase, is membrane bound and is associated with the ammonia channel Amt [59]. Our
BLAST searches for B. subtilis NrgA (codes for Amt) in C. difficile genomes did not identify a
homologue. Similar BLAST searches for possible alpha-keto glutarate transporters [using the
sequence of Bacillus licheniformis dicarboxylate transporter- [60]] also didn’t identify a homo-
logue in C. difficile. It is not clear if these initial failures using in silico analyses correctly indicate
that these transporters are absent in C. difficile, or if the C. difficile transporter is evolutionarily
distant.
Finally, we note that community-acquired C. difficile infections have been on the rise in the
past decade [61]. Reasons for the increase in these infections are not yet clear, but a possiblity is
suggested by the fact that monosodium glutamate is used extensively as a food preservative
[62]. Our study raises the question of whether frequent consumption of monosodium gluta-
mate influences the rate of community-acquired C. difficile infection. Detailed studies aimed at
investigating the role of host nutrient uptake on C. difficile colonization are needed.
Supporting Information
S1 Fig. GDH ELISA. Detecting GDH in the cecal contents of the hamsters infected with either
JIR8094 or gluDmutants using ELISA (CDiff Check ™- 60, TechLab Inc). GDH was readily
detected in all seven hamsters challenged with JIR8094 strain, but not from the gluDmutant
challenged hamsters. Student t test was performed and the  indicates p value of<0.001
(PDF)
S2 Fig. Growth curve of parent and gluDmutant strains. Bacterial strains were inoculated
and were grown overnight in TY medium with thiamphenicol (15 μg/ml). Then 100 μl of the
overnight culture was used to inoculate fresh 10 ml medium and the turbidity of the culture
was monitored every 4 hours spectrometrically at OD600nms.
(PDF)
S3 Fig. Survival curve of the mixed infection study. Kaplan-Meier survival curve of clinda-
mycin-treated Syrian hamsters inoculated with 2,000 C. difficile cells (either Parent; or gluD
mutant; or 1000 Parent+ 1000 gluDmutant cells). Animals were monitored every four hours
for the symptoms of wet tail, poor fur coat, lethargy, hunch posture and were scored from 1–5.
A cumulative score of 12 was assigned as the euthanization point.
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S4 Fig. Hamster groups used in the cecal amino acid analyses. Schematic diagram of the
hamster groups used for the cecal amino acid analyses experiment.
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